| Matthew Reiser, PHD | |
|
292 S 1470 E Fl 3, St George, UT 84790-1763 | |
| (435) 251-5900 | |
| (435) 251-5901 |
| Full Name | Matthew Reiser |
|---|---|
| Gender | Male |
| Speciality | Clinical Psychologist |
| Experience | 12 Years |
| Location | 292 S 1470 E Fl 3, St George, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750710455 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC1900X | Psychologist - Counseling | 5184406-2501 (Utah) | Secondary |
| 103T00000X | Psychologist | (Utah) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Intermountain Healthcare Services, Inc | 1850209420 | 3063 |
News Archive
The monoclonal antibody nivolumab has shown promise as a therapeutic agent, particularly by improving the survival rates of melanoma patients. Jeffrey S. Weber, M.D., Ph.D., director of the Donald A. Adam Comprehensive Melanoma Research Center at Moffitt Cancer Center will be presenting data from a retrospective analysis of the safety of nivolumab in 4 ongoing phase I-III studies in melanoma patients at the 2015 American Society of Clinical Oncology Annual Meeting in Chicago.
"Optimism and momentum has been building around the real possibility that an AIDS-free generation is imminent. Yet, the most recent estimates of HIV prevalence and incidence and of AIDS-related mortality released by UNAIDS, together with data from the Global Burden of Disease Study 2010 in the Lancet, make it clear that AIDS is not over," UNAIDS Executive Director Michel Sidibe; Peter Piot, director of the London School of Hygiene and Tropical Medicine; and Mark Dybul, incoming executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, write in a Lancet opinion piece.
Preliminary evidence suggests that a combination of dieting and exercise is a more effective way of losing weight after pregnancy than dieting alone, concludes a Cochrane Systematic Review.
MRO Corp., a leading provider of disclosure management applications and services for healthcare organizations, today announced a contract with UC Health University Hospital (Cincinnati, Ohio) to provide ROI processing services to the facility. Under this agreement, University Hospital will incorporate MRO's ROI technology with its existing electronic medical record system. The new workflow enables the organization to bring its ROI process in-house and partner with MRO to provide the back-office fulfillment functions.
› Verified 1 days ago
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942325154 PECOS PAC ID: 1850209420 Enrollment ID: O20080610000303 |
News Archive
The monoclonal antibody nivolumab has shown promise as a therapeutic agent, particularly by improving the survival rates of melanoma patients. Jeffrey S. Weber, M.D., Ph.D., director of the Donald A. Adam Comprehensive Melanoma Research Center at Moffitt Cancer Center will be presenting data from a retrospective analysis of the safety of nivolumab in 4 ongoing phase I-III studies in melanoma patients at the 2015 American Society of Clinical Oncology Annual Meeting in Chicago.
"Optimism and momentum has been building around the real possibility that an AIDS-free generation is imminent. Yet, the most recent estimates of HIV prevalence and incidence and of AIDS-related mortality released by UNAIDS, together with data from the Global Burden of Disease Study 2010 in the Lancet, make it clear that AIDS is not over," UNAIDS Executive Director Michel Sidibe; Peter Piot, director of the London School of Hygiene and Tropical Medicine; and Mark Dybul, incoming executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, write in a Lancet opinion piece.
Preliminary evidence suggests that a combination of dieting and exercise is a more effective way of losing weight after pregnancy than dieting alone, concludes a Cochrane Systematic Review.
MRO Corp., a leading provider of disclosure management applications and services for healthcare organizations, today announced a contract with UC Health University Hospital (Cincinnati, Ohio) to provide ROI processing services to the facility. Under this agreement, University Hospital will incorporate MRO's ROI technology with its existing electronic medical record system. The new workflow enables the organization to bring its ROI process in-house and partner with MRO to provide the back-office fulfillment functions.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew Reiser, PHD Po Box 27128, Salt Lake City, UT 84127-0128 Ph: () - | Matthew Reiser, PHD 292 S 1470 E Fl 3, St George, UT 84790-1763 Ph: (435) 251-5900 |
News Archive
The monoclonal antibody nivolumab has shown promise as a therapeutic agent, particularly by improving the survival rates of melanoma patients. Jeffrey S. Weber, M.D., Ph.D., director of the Donald A. Adam Comprehensive Melanoma Research Center at Moffitt Cancer Center will be presenting data from a retrospective analysis of the safety of nivolumab in 4 ongoing phase I-III studies in melanoma patients at the 2015 American Society of Clinical Oncology Annual Meeting in Chicago.
"Optimism and momentum has been building around the real possibility that an AIDS-free generation is imminent. Yet, the most recent estimates of HIV prevalence and incidence and of AIDS-related mortality released by UNAIDS, together with data from the Global Burden of Disease Study 2010 in the Lancet, make it clear that AIDS is not over," UNAIDS Executive Director Michel Sidibe; Peter Piot, director of the London School of Hygiene and Tropical Medicine; and Mark Dybul, incoming executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, write in a Lancet opinion piece.
Preliminary evidence suggests that a combination of dieting and exercise is a more effective way of losing weight after pregnancy than dieting alone, concludes a Cochrane Systematic Review.
MRO Corp., a leading provider of disclosure management applications and services for healthcare organizations, today announced a contract with UC Health University Hospital (Cincinnati, Ohio) to provide ROI processing services to the facility. Under this agreement, University Hospital will incorporate MRO's ROI technology with its existing electronic medical record system. The new workflow enables the organization to bring its ROI process in-house and partner with MRO to provide the back-office fulfillment functions.
› Verified 1 days ago
Dr. Christina J Durham, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 166 N 300 W, Suite 1, St George, UT 84770 Phone: 435-688-9471 Fax: 435-688-9478 | |
Tim R Kockler, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 1224 S. River Road, Suite 221, St George, UT 84790 Phone: 435-632-1445 Fax: 435-688-1091 | |
David Brent Tate, PH.D. Psychologist Medicare: May Accept Medicare Assignments Practice Location: 321 N Mall Dr, Suite I-201, St George, UT 84790 Phone: 435-656-0506 Fax: 435-272-4009 | |
Dr. Virgil W. Brockbank, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2480 Red Cliffs Dr, St George, UT 84790 Phone: 435-673-6446 Fax: 435-652-8020 | |
Paul Staheli, PHD Psychologist Medicare: Medicare Enrolled Practice Location: 474 W 200 N, Suite 100, St George, UT 84770 Phone: 435-634-5600 Fax: 435-986-8700 | |
Allen Garrett, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 474 W 200 N, St George, UT 84770 Phone: 435-634-5600 | |
Chauncey Sandberg Adams, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 544 S 400 E, St George, UT 84770 Phone: 435-688-4343 |